Literature DB >> 9696644

Bosentan in essential hypertension.

W G Haynes, C J Ferro, D J Webb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9696644     DOI： 10.1056/NEJM199807303390513

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 2.  Endothelin and its antagonists in hypertension: can we foresee the future?

Authors:  P Moreau; T J Rabelink
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

3.  ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.

Authors:  M-L Gross; N Heiss; M Weckbach; A Hansen; A El-Shakmak; A Szabo; K Münter; E Ritz; K Amann
Journal:  Diabetologia       Date:  2004-01-15       Impact factor: 10.122
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.